Features
Medication Reviews Can Help Patients With Diabetes
Pharmacists are key providers in the continuum of care, consistently identifying potential problems and concerns that may require follow-up.
Study: Affordable Care Act Improved Insurance Coverage for People With Both Cancer, HIV
A recent study indicates that for patients with both HIV and cancer, the Patient Protection and Affordable Care Act (ACA) improved insurance coverage.
The Immunization Treatment Landscape
A discussion on the current rates of immunization amongst various age groups, and how to effectively administer vaccines to the general population.
Latest News
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss the goals and importance of his company, Stack, during the NASP Annual Meeting in Washington, DC.
Walter Wong, PharmD, owner of Green Valley Pharmacy in Rancho Cucamongo, CA speaks to Pharmacy Times about how his employees and why their wellbeing matters.
The American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting is approaching, and Pharmacy Times® will be on-site to provide comprehensive coverage from Las Vegas, Nevada. ASHP Midyear 2019 will take place December 8 to 12, 2019.
Top news of the week from Specialty Pharmacy Times.
Crizanlizumab-tmca (Adakveo, Novartis) is approved to reduce the frequency of vaso-occlusive crises in patients aged 16 years and older with sickle cell disease.
Previously, vaccination was not recommended for patients in a certain age range, as there was no demonstrated benefit to HPV vaccination; however, this is about to change.
Top news of the day from across the health care landscape.
Cefiderocol (Fetroja, Shionogi) is indicated for adults with complicated urinary tract infections, including kidney infections caused by Gram-negative pathogens, who have limited or no alternative treatment options.
Cenobamate is an investigational antiepileptic drug that has shown broad spectrum anticonvulsant activity in preclinical studies and seizure models.
The FDA granted accelerated approval to zanubrutinib (Brukinsa, BeiGene) for the treatment of mantle cell lymphoma in adults who have received at least 1 prior therapy.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how vertical integration might affect biosimilar availability in specialty pharmacy during the NASP Annual Meeting in Washington, DC.
+ Load More
